Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV-associated liver disease

This publication has 44 references indexed in Scilit:

• A Simple Noninvasive Index Can Predict Both Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis C
  Hepatology, 2003
• Noninvasive monitoring of patients with chronic hepatitis C
  Hepatology, 2002
• Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
  Hepatology, 2002
• Measurement of serum hyaluronic acid in patients with chronic hepatitis C and its relationship to liver histology
  Journal of Gastroenterology and Hepatology, 2000
• Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?
  Journal of Gastroenterology and Hepatology, 2000
• Biochemical and virological outcome of patients with chronic hepatitis C treated with interferon alfa-2b for 6 or 12 months: A 4-year follow-up of 211 patients
  Hepatology, 1997
• Comparison of serum 7S fragment of type IV collagen and serum central triple-helix of type IV collagen for assessment of liver fibrosis in patients with chronic viral liver disease
  Journal of Hepatology, 1996
• Serum YKL-40: A new potential marker of prognosis and location of métastases of patients with recurrent breast cancer
  European Journal Of Cancer, 1995
• Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C
  Journal of Hepatology, 1994
• Aminoterminal Propeptide of Type III Procollagen is Cleared from the Circulation by Receptor-Mediated Endocytosis in Liver Endothelial Cells
  Collagen and Related Research, 1988